Life Healthcare Group Holdings Limited (JSE:LHC)

Market Cap	17.29B -8.6%
Revenue (ttm)	25.68B +3.2%
Net Income	6.77B
EPS	4.73
Shares Out	1.43B
PE Ratio	12.87
Forward PE	9.48
Dividend	0.70 (6.07%)
Ex-Dividend Date	Jun 17, 2026

Volume	3,874,567
Open	1,169.00
Previous Close	1,175.00
Day's Range	1,169.00 - 1,217.00
52-Week Range	1,000.00 - 1,410.00
Beta	0.08
Analysts	Buy
Price Target	1,265.00 (+4.72%)
Earnings Date	Nov 26, 2026

About JSE:LHC

Life Healthcare Group Holdings Limited, an investment holding company, operates as a private healthcare company in Southern Africa. It operates through Southern Africa – Hospitals Services, Southern Africa - Complementary Services, Southern Africa - Healthcare Services, and International segments. The company operates acute hospitals; and Life Nkanyisa care centres that provide long-term chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, primary healthcare, and substance abuse recovery programme service...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 20,436
• Stock Exchange: Johannesburg Stock Exchange
• Ticker Symbol: LHC

Financial Performance

In fiscal year 2025, JSE:LHC's revenue was 25.40 billion, an increase of 6.06% compared to the previous year's 23.95 billion. Earnings were 3.78 billion, a decrease of -20.38%.

Analyst Summary

According to 5 analysts, the average rating for LHC stock is "Buy." The 12-month stock price target is ZAC 1,265, which is an increase of 4.72% from the latest price.

Price Target

ZAC 1,265

(4.72% upside)

Analyst Consensus: Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 9, 2026

Data Sources Report a data error